A perspective on multi-target drug discovery and design for complex diseases

Area of Science:

• Drug discovery and medicinal chemistry
• Computational biology and bioinformatics
• Translational science

Background:

• Infectious, neurodegenerative (e.g., Alzheimer's, Parkinson's), and malignant (cancers) diseases have multifaceted origins.
• Modern drug discovery screens millions of compounds for potential therapeutic targets.
• Computational approaches accelerate the identification of drug candidates by predicting molecular interactions.

Purpose of the Study:

• To highlight molecular and computational strategies in drug design.
• To foster collaboration between medicinal chemists and clinical scientists.
• To provide an overview of computational drug discovery methods.

Main Methods:

• Focus on molecular modeling and computational simulations.
• Utilizing databases of compounds and validated biological targets.
• In silico screening and virtual drug design.

Main Results:

• Computational methods enable target-compound association prediction prior to synthesis.
• This approach streamlines the drug discovery pipeline.
• Facilitates the identification of novel drug candidates for complex diseases.

Conclusions:

• Molecular and computational approaches are integral to modern drug design.
• Predictive modeling enhances efficiency and reduces costs in drug discovery.
• Enhanced understanding and collaboration are key to advancing therapeutic development.